Study
Mushroom Supplement May Improve Memory in Older Adults
Taking Yamabushitake mushroom supplements improved cognitive function in seniors with mild memory issues.
Memory SupportHealthy AgingSupplement
Summary
In plain language
A study found that seniors aged 50 to 80 with mild cognitive impairment experienced improved memory function after taking Yamabushitake mushroom supplements. Participants who took these supplements for 16 weeks showed better cognitive scores compared to those who took a placebo. However, the benefits decreased after stopping the supplement. This suggests that continuous intake may be necessary to maintain the positive effects. Importantly, no serious side effects were reported, making it a potentially safe option for those looking to support their cognitive health. Seniors interested in natural ways to boost memory might consider discussing this option with their healthcare providers.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
The study was a double-blind, placebo-controlled trial involving 30 Japanese seniors with mild cognitive impairment. Participants were divided into two groups, one receiving the Yamabushitake supplement and the other a placebo, for 16 weeks.
Results showed that the group taking Yamabushitake had improved cognitive scores, which were measured using a specialized dementia scale.
After stopping the supplement, the benefits diminished, indicating the need for ongoing use for lasting effects.
No significant adverse effects were found, although some mild stomach discomfort was reported in both groups.
Seniors considering this supplement should talk to their healthcare providers to ensure it's a suitable choice for their health needs.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Mushroom Supplement May Improve Memory in Older Adults
Published May 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
The study is well-designed with strong bias control and appropriate statistical methods. However, the small sample size and lack of replication limit its generalizability. Transparency could be improved with protocol registration and data sharing. The study is relevant to a mixed-age population, including seniors.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 8.3/10 | |
| Bias & Methods | 10.0/10 | |
| Statistical Integrity | 10.0/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 5.0/10 | |
| Replication / External Validation | 0.0/10 | |
| Relevance to Seniors | 5.0/10 | |
| Journal Quality | 10.0/10 |
Additional Notes
The study's findings are promising but should be interpreted with caution due to the small sample size and lack of replication. Further research with larger samples and independent validation is recommended.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.